Dexcom’s G7 Expands Globally After A Long Wait
Executive Summary
Dexcom has expanded the availability of its G7 sensor to five new markets, including the UK and Germany. FDA approval in the US has been delayed by software changes.
You may also be interested in...
News We’re Watching: Dexcom Expands In Ireland; Neurostim Updates From NANS; Novel Nanoparticles Treat Cancer In Mice; And More
Medtech Insight's News We're Watching highlights medtech industry and R&D developments that you may have missed over the last few weeks. This update covers some late-breaking results announced at the North American Neuromodulation Society (NANS) annual meeting in Las Vegas, as well as an update on Dexcom's new facility in Ireland, and a promising mouse experiment with nanoparticles that kill cancer cells.
Digital Health Roundup: Telehealth Strong, Diabetes Recalls And Expansions, AI And Radiology
In this month’s Digital Health Roundup, Medtech Insight’s Reed Miller offers a recap from the recent TCT 2022 meeting and talks about Butterfly Network’s expansion into Africa while Marion Webb highlights her interview with Aidoc’s CEO Elad Walach discussing plans for the AI-based software company.
FDA Clears Abbott’s Libre 3
Abbott’s FreeStyle Libre 3 system will soon be available in the US. It is 70% smaller than the Libre 2 while also providing better accuracy.